324 related articles for article (PubMed ID: 30075518)
1. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
[TBL] [Abstract][Full Text] [Related]
2. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
[TBL] [Abstract][Full Text] [Related]
3. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
[TBL] [Abstract][Full Text] [Related]
4. Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study.
Fukushima M; Miyaaki H; Sasaki R; Haraguchi M; Miuma S; Hara T; Soyama A; Hidaka M; Eguchi S; Nakao K
Intern Med; 2023 May; 62(10):1415-1423. PubMed ID: 36171128
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
6. Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease.
Bezinover D; Alhkouri N; Schumann R; Geyer N; Chinchilli V; Stine JG
Transplant Proc; 2023 Nov; 55(9):2134-2142. PubMed ID: 37752016
[TBL] [Abstract][Full Text] [Related]
7. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
[TBL] [Abstract][Full Text] [Related]
8. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
[TBL] [Abstract][Full Text] [Related]
9. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients.
Stepanova M; Kabbara K; Mohess D; Verma M; Roche-Green A; AlQahtani S; Ong J; Burra P; Younossi ZM
Hepatol Commun; 2022 Jul; 6(7):1506-1515. PubMed ID: 35224886
[TBL] [Abstract][Full Text] [Related]
11. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy.
Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613
[No Abstract] [Full Text] [Related]
12. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
[TBL] [Abstract][Full Text] [Related]
13. Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis.
Loy VM; Joyce C; Bello S; VonRoenn N; Cotler SJ
Clin Transplant; 2018 Aug; 32(8):e13297. PubMed ID: 29804305
[TBL] [Abstract][Full Text] [Related]
14. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
15. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
[TBL] [Abstract][Full Text] [Related]
16. International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation.
Tsochatzis E; Coilly A; Nadalin S; Levistky J; Tokat Y; Ghobrial M; Klinck J; Berenguer M
Transplantation; 2019 Jan; 103(1):45-56. PubMed ID: 30153225
[TBL] [Abstract][Full Text] [Related]
17. Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand.
Calzadilla-Bertot L; Jeffrey GP; Jacques B; McCaughan G; Crawford M; Angus P; Jones R; Gane E; Munn S; Macdonald G; Fawcett J; Wigg A; Chen J; Fink M; Adams LA
Liver Transpl; 2019 Jan; 25(1):25-34. PubMed ID: 30609187
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
19. Predicting the outcome of liver transplantation in patients with non-alcoholic steatohepatitis cirrhosis: The NASH LT risk-benefit calculator.
Karnam RS; Punchhi G; Mitsakakis N; Chen S; Saracino G; Lilly L; Asrani SK; Bhat M
Clin Transplant; 2023 Apr; 37(4):e14930. PubMed ID: 36762716
[TBL] [Abstract][Full Text] [Related]
20. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
